Kerecis Ltd.

Works in Cardiovascular · Dermatology · Genetic & rare · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Respiratory

Kerecis Ltd. is a clinical trial sponsor. It has 8 active clinical trials with 1,595 planned participants, across 8 therapeutic areas. Since 2021 it has completed 4 trials and stopped 0 early.

Trial track record · since 2021

8Active trials1,595 planned participants
4Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 8 active trials

StageTrialStatus

Questions about Kerecis Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-01-08.

Approve Suite is not affiliated with Kerecis Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.